FDA Clears Clew AI-Based Predictive Analytics for Adult ICU Patient Assessment
The artificial intelligence-based ClewICU solution has been cleared to predict hemodynamic instability in adult patients.
Read MorePosted by Melanie Hamilton-Basich | Feb 5, 2021 | Covid 19, Middleware & Software |
The artificial intelligence-based ClewICU solution has been cleared to predict hemodynamic instability in adult patients.
Read MorePosted by Laurie Bonner | Feb 5, 2021 | Company News, Covid 19, Molecular Diagnostics |
The partnership will combine Tecan’s liquid handling and automation expertise with UgenTec’s FastFinder software to provide high-throughput solutions for molecular testing.
Read MorePosted by Laurie Bonner | Feb 5, 2021 | Covid 19, Molecular Diagnostics |
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read MorePosted by Laurie Bonner | Feb 5, 2021 | Covid 19, Flu & Respiratory Infections |
This winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read MorePosted by Laurie Bonner | Feb 4, 2021 | Covid 19, Molecular Diagnostics |
T2 Biosystems’ panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the United States.
Read More